☆ 4.7 Article

Multiplexed on-yeast serological assay for immune escape screening of SARS-CoV-2 variants

ISCIENCE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Virology

The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 Omicron variant

Dandan Tian et al.

Summary: The Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in Botswana in November 2021 and has since become the dominant strain in many countries. With a high number of mutations, it presents new challenges for preventing and controlling COVID-19. This review aims to provide a scientific reference by analyzing and summarizing the biological characteristics, epidemic features, immune escape, and vaccine reactivity of the Omicron variant.

JOURNAL OF MEDICAL VIROLOGY (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization

Delphine Planas et al.

Summary: The Omicron variant of SARS-CoV-2, identified in November 2021, has spread rapidly worldwide and shows resistance to most therapeutic monoclonal antibodies and vaccine-elicited antibodies. However, it can be neutralized by antibodies generated by a booster vaccine dose.

NATURE (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination

Samuel M. S. Cheng et al.

Summary: Specific antibody levels against the SARS-CoV-2 Omicron variant decrease significantly after two doses of BNT162b2 or CoronaVac vaccines, but can be markedly increased with a booster dose of BNT162b2. Individuals who previously received two doses of BNT162b2 or CoronaVac showed reduced serum antibody titers against Omicron, while a BNT162b2 booster dose increased the antibody levels in the majority of individuals. This suggests mRNA vaccine boosters may be necessary in countries primarily using CoronaVac vaccines to combat the spread of Omicron.

NATURE MEDICINE (2022)

添加到收藏夹

Article Cell Biology

SARS-CoV-2 reactive and neutralizing antibodies discovered by single-cell sequencing of plasma cells and mammalian display

Roy A. Ehling et al.

Summary: This study presents a technology pipeline that combines single-cell antibody repertoire sequencing and mammalian display to investigate the specificity of plasma cells from convalescent COVID-19 patients. The results reveal specific antibodies targeting SARS-CoV-2 antigens, including those with high affinity and broad binding to the receptor binding domain (RBD) of SARS-CoV-2 variants.

CELL REPORTS (2022)

添加到收藏夹

Article Biology

Microfluidic characterisation reveals broad range of SARS-CoV-2 antibody affinity in human plasma

Matthias M. Schneider et al.

Summary: The clinical outcome of SARS-CoV-2 infections is influenced by the concentration and affinity of antiviral antibodies, which are difficult to measure in polyclonal antibody responses in plasma. Using microfluidic antibody affinity profiling (MAAP), researchers were able to determine the affinities and concentrations of anti-SARS-CoV-2 antibodies in plasma samples. The study found that MAAP could accurately predict the cellular neutralization ability of sera, making it a potentially valuable tool for therapeutic plasma exchange and monitoring vaccination success.

LIFE SCIENCE ALLIANCE (2022)

添加到收藏夹

Article Nanoscience & Nanotechnology

Poly(methyl methacrylate)-Based Nanofluidic Device for Rapid and Multiplexed Serological Antibody Detection of SARS-CoV-2

Thomas Mortelmans et al.

Summary: The development of a three-dimensional nanofluidic device for rapid and multiplexed detection of viral antibodies is presented. The device is made from poly(methyl methacrylate) and utilizes nanoscale topography variations for particle immobilization and trapping. It can be used for specific and sensitive multiplexed detection of serological antibodies against different viral proteins. The device's applications can be extended to detect various diseases simultaneously.

ACS APPLIED NANO MATERIALS (2022)

添加到收藏夹

Article Medicine, General & Internal

Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant

Maren Schubert et al.

Summary: This study analyzed the binding ability of the Omicron variant to the human receptor and its neutralization efficacy. The results showed weaker binding and complete loss of neutralization against Omicron compared to previous variants. However, booster vaccination increased the antibody levels and partially restored neutralization against Omicron SARS-CoV-2.

BMC MEDICINE (2022)

添加到收藏夹

Article Immunology

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort Study

Sivan Gazit et al.

Summary: The study compared the long-term protection of naturally acquired immunity to vaccine-induced immunity against SARS-CoV-2. The findings suggest that natural immunity provides stronger protection against infection and symptomatic disease caused by the Delta variant compared to the BNT162b2 vaccine-induced immunity.

CLINICAL INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Ultrasensitive detection of salivary SARS-CoV-2 IgG antibodies in individuals with natural and COVID-19 vaccine-induced immunity

Stefani N. Thomas et al.

Summary: The feasibility of using a highly sensitive immunoassay method based on Simoa technology to detect SARS-CoV-2 antibodies in saliva was assessed. The method showed significantly higher analytical sensitivity compared to the traditional ELISA method. The findings support the use of concentrated saliva specimens for ELISA and unconcentrated saliva specimens for the Simoa immunoassay.

SCIENTIFIC REPORTS (2022)

添加到收藏夹

Article Chemistry, Multidisciplinary

Antibody-Invertase Fusion Protein Enables Quantitative Detection of SARS-CoV-2 Antibodies Using Widely Available Glucometers

Elissa K. Leonard et al.

Summary: Rapid and accurate diagnostics are crucial for controlling the COVID-19 pandemic and future infectious disease outbreaks. Researchers have developed a novel enzymatic reporter that can detect disease-specific antibodies by producing glucose when binding to patient antibodies. The fusion protein used in this method has shown precise agreement with commercial immunoassays, making it a versatile tool for detecting disease-specific antibodies.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution

Tyler N. Starr et al.

Summary: This study investigates the impact of mutations in the spike receptor-binding domain (RBD) of SARS-CoV-2 on its affinity for the ACE2 receptor and antibody recognition, as well as their implications for future evolution and interaction. The findings reveal that certain mutations cause shifts in the effects of mutations at other sites, shaping the evolutionary path of the virus.

SCIENCE (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Deep mutational learning predicts ACE2 binding and antibody escape to combinatorial mutations in the SARS-CoV-2 receptor-binding domain

Joseph M. Taft et al.

Summary: The development of deep mutational learning (DML), a machine-learning-guided protein engineering technology, allows accurate prediction of the impact of SARS-CoV-2 variants on ACE2 binding and antibody escape. A highly diverse landscape of possible SARS-CoV-2 variants is identified, and this technology can be used for predictive profiling of current and prospective variants, including highly mutated variants such as Omicron, to guide the development of therapeutic antibody treatments and vaccines for COVID-19.

CELL (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Prospective mapping of viral mutations that escape antibodies used to treat COVID-19

Tyler N. Starr et al.

Summary: Research has found that mutations in the receptor binding domain (RBD) of SARS-CoV-2 may potentially escape the action of the REGN-COV2 cocktail, providing important information for interpreting mutations observed during viral surveillance.

SCIENCE (2021)

添加到收藏夹

Article Cell Biology

IgA dominates the early neutralizing antibody response to SARS-CoV-2

Delphine Sterlin et al.

Summary: The study found that humoral immune responses to SARS-CoV-2 infection are dominated by IgA antibodies, with specific IgA plasmablasts rapidly expanding shortly after symptom onset and peaking in the third week of the disease. Virus-specific antibody responses include IgG, IgM, and IgA, with IgA playing a greater role in virus neutralization compared to IgG.

SCIENCE TRANSLATIONAL MEDICINE (2021)

添加到收藏夹

Article Microbiology

Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies

Allison J. Greaney et al.

Summary: The evolution of SARS-CoV-2 may impact the recognition of the virus by human antibody-mediated immunity, with mutations affecting antibody binding varying significantly among individuals and within the same individual over time. Despite this variability, mutations that greatly reduce antibody binding usually occur at specific sites in the RBD, with E484 being the most crucial. These findings can inform surveillance efforts for SARS-CoV-2 evolution in the future.

CELL HOST & MICROBE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies

Allison J. Greaney et al.

Summary: The study found that although the human immune system can produce antibodies that target diverse RBD epitopes, in practice, the polyclonal response to infection tends to be skewed towards a single class of antibodies targeting an epitope that is already undergoing rapid evolution.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Medicine, General & Internal

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia

Qun Li et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Markus Hoffmann et al.

CELL (2020)

添加到收藏夹

Article Virology

Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins

Suhas Srinivasan et al.

VIRUSES-BASEL (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Structural basis of receptor recognition by SARS-CoV-2

Jian Shang et al.

NATURE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding

Tyler N. Starr et al.

CELL (2020)

添加到收藏夹

Article Biology

How to measure and evaluate binding affinities

Inga Jarmoskaite et al.

ELIFE (2020)

添加到收藏夹

Review Neurosciences

The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections

Jatin Machhi et al.

JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2020)

添加到收藏夹

Article Infectious Diseases

SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case series

Ivan Fan-Ngai Hung et al.

LANCET INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Engineered ACE2 receptor traps potently neutralize SARS-CoV-2

Anum Glasgow et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

添加到收藏夹

Correction Biochemistry & Molecular Biology

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein (vol 180, 281.e1, 2020)

Alexandra C. Walls et al.

CELL (2020)

添加到收藏夹

Article Biochemical Research Methods

Nextstrain: real-time tracking of pathogen evolution

James Hadfield et al.

BIOINFORMATICS (2018)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate

Wen-Hsiang Chen et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)

添加到收藏夹

Article Biochemical Research Methods

Miniaturized receptor binding assays: Complications arising from ligand depletion

Clare M. Scaramellini Carter et al.

JOURNAL OF BIOMOLECULAR SCREENING (2007)

添加到收藏夹

Article Biochemical Research Methods

Isolating and engineering human antibodies using yeast surface display

Ginger Chao et al.

NATURE PROTOCOLS (2006)

添加到收藏夹

Article Multidisciplinary Sciences

Structure of SARS coronavirus spike receptor-binding domain complexed with receptor

F Li et al.

SCIENCE (2005)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.